Valeant raises bid for Allergan values Botox-maker at $49.44 billion - UK source
(Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) raised the cash component of its offer for Botox-maker Allergan Inc (AGN.N), valuing the U.S. firm at $49.44 billion (29.51 billion pounds). Valeant on Wednesday offered to pay $58.30 per Allergan share in...